← All organizations

TEMPUS

For profitWebsite ↗

Also known as: Tempus AI | Tempus Labs | Tempus Labs, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Apr 30, 2026

Timeline

2010s

Jan 1, 2015
TEMPUS— Founded

Drugs by trial phase (6 distinct, 6 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

rebecsinib

Indications

Studied for

Recent trials (6)

NCT07250646CollaboratorPhase 1Apr 30, 2026
NCT06051695CollaboratorPhase 1/Phase 2Mar 31, 2024
NCT05736731CollaboratorPhase 1/Phase 2Apr 28, 2023
NCT05169437Lead sponsorPhase 2Mar 15, 2022
NCT00277862CollaboratorPhase 4Apr 1, 2002
NCT00241618CollaboratorPhase 4Jan 1, 2002

Details

Founded: Chicago, IL, US Jan 1, 2015
Last known activity: Apr 30, 2026